SPC104
Sovaldi (sófosbúvír)
Status:
VeittApplication date:
18.11.2014Application published:
15.12.2014Grant published:
15.4.2016
Max expiry date:
16.7.2029Medicine name:
Sovaldi - sofosbuvirMedicine for children:
Yes
Timeline
Today
18.11.2014Application
15.12.2014Publication
15.4.2016Registration
16.7.2029Expires
Marketing license
IS authorization number:
EU/1/13/894/001-002Date:
6.2.2014
Foreign authorization number:
EU/1/13/894/001-002Date:
16.1.2014
Owner
Name:
Gilead Pharmasset LLCAddress:
c/o Gilead Sciences, Inc., 333 Lakeside Drive, Foster City US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2203462